PLASMA CELL MYELOMA REFRACTORY
Clinical trials for PLASMA CELL MYELOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL MYELOMA REFRACTORY trials appear
Sign up with your email to follow new studies for PLASMA CELL MYELOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot shows promise for Hard-to-Treat blood cancer
Disease control Recruiting nowThis study tests a new antibody drug (SAR446523) given as a shot under the skin for people with multiple myeloma that has come back or stopped responding to treatment. The goal is to find the safest and most effective dose, and to see if it can shrink tumors. About 87 adults will…
Matched conditions: PLASMA CELL MYELOMA REFRACTORY
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 09:42 UTC
-
New hope for myeloma patients: umbrella trial explores smarter drug combos
Disease control Recruiting nowThis study is for people with multiple myeloma that has come back or stopped responding to treatment. It tests a drug called isatuximab combined with other new drugs, with or without dexamethasone, to see if these combinations work better than the current standard. About 258 adul…
Matched conditions: PLASMA CELL MYELOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New injection method for multiple myeloma drug tested in 64 patients
Disease control Recruiting nowThis study tests a new way to give the drug isatuximab using a small device worn on the body, along with two other drugs (carfilzomib and dexamethasone), for people with multiple myeloma that has come back or not responded to treatment. The goal is to see if this combination help…
Matched conditions: PLASMA CELL MYELOMA REFRACTORY
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 08:19 UTC